Research Topics
| Marjolein van BallegooijenSummaryAffiliation: Erasmus MC Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Simulation of colorectal cancer screening: what we do and do not know and does it matterMarjolein van Ballegooijen
Department of Public Health, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands
Best Pract Res Clin Gastroenterol 24:427-37. 2010..Thus it is important to further develop the quality and acceptability of simulation, especially that for colorectal cancer screening...
Simulation of colorectal cancer screening: What we do and do not know and does it matterMarjolein van Ballegooijen
Department of Public Health, Erasmus MC, P O Box 2040, 3000 CA Rotterdam, The Netherlands
Best Pract Res Clin Anaesthesiol 24:427-37. 2010..Thus it is important to further develop the quality and acceptability of simulation, especially that for colorectal cancer screening...
Clarifying differences in natural history between models of screening: the case of colorectal cancerMarjolein van Ballegooijen
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Med Decis Making 31:540-9. 2011..The authors demonstrate this problem and explore a solution for natural history using 3 independently developed colorectal cancer screening models...- Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trialThomas R de Wijkerslooth
Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands
BMC Gastroenterol 10:47. 2010.... - Effect of rising chemotherapy costs on the cost savings of colorectal cancer screeningIris Lansdorp-Vogelaar
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
J Natl Cancer Inst 101:1412-22. 2009..We examined whether colorectal cancer screening would become cost saving with the widespread use of the newer, more expensive chemotherapies... - Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategiesMatejka Rebolj
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Int J Cancer 121:1529-35. 2007..Therefore, we advocate including HPV testing before referring to colposcopy. Among the 3 HPV strategies, analysis of additional aspects favors implementation of immediate HPV testing... - Fecal occult blood testing when colonoscopy capacity is limitedJanneke A Wilschut
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
J Natl Cancer Inst 103:1741-51. 2011..Which of these options is most clinically effective and cost-effective has yet to be established... - Individualizing colonoscopy screening by sex and raceIris Lansdorp-Vogelaar
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Gastrointest Endosc 70:96-108, 108.e1-24. 2009..There is increasing discussion whether colorectal cancer (CRC) screening guidelines should be individualized by sex and race... - Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programmeLieke Hol
Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
Int J Cancer 130:2096-102. 2012..Women in the target population were more likely to refuse FS than FIT screening. Countries introducing FS screening should be aware of these preferences... - Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screeningJanneke A Wilschut
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
Gastroenterology 141:1648-55.e1. 2011..We aimed to identify the most cost-effective FIT cutoff level for referral to colonoscopy based on data from these trials and allowing for differences in screening ages... - Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent diseaseAagje G Bais
Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
Int J Cancer 124:889-95. 2009..We advise combined cytology and hrHPV testing at 6, 12 and 24 months after treatment. Low-risk women may omit the 12 months visit, resulting in cost reduction... - Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programsAagje G Bais
Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
Int J Cancer 120:1505-10. 2007..euro 7,599). Offering self-sampling for hrHPV testing in nonresponders is an attractive adjunct to effectively increase population coverage of screening without the adverse effect of markedly increased costs per detected CIN2+ lesion... - Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysisIris Lansdorp-Vogelaar
Erasmus Medical Center, Rotterdam, The Netherlands
Ann Intern Med 153:368-77. 2010..The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees... - Incidence of cervical cancer after several negative smear results by age 50: prospective observational studyMatejka Rebolj
Erasmus MC, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
BMJ 338:b1354. 2009..To determine the incidence of cervical cancer after several negative cervical smear tests at different ages... - Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trialAafke H C van Roon
Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
Am J Gastroenterol 107:99-107. 2012..However, hemoglobin (Hb) degradation over time may influence FIT outcome. We therefore evaluated the effect of sample return time on FIT performance characteristics in a population-based CRC screening trial... - How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?Janneke A Wilschut
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Cancer 117:4166-74. 2011..The authors investigated optimal screening strategies for individuals with various degrees of family history of CRC based on a cost-effectiveness analysis... - Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screeningPaul G van Putten
Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
Histopathology 58:974-81. 2011..To determine the inter-observer variation in the histological diagnosis of colorectal polyps... - Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort studyMatejka Rebolj
Department of Public Health, Erasmus MC, Rotterdam, Netherlands
BMJ 345:e6855. 2012.... - Contribution of screening and survival differences to racial disparities in colorectal cancer ratesIris Lansdorp-Vogelaar
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Cancer Epidemiol Biomarkers Prev 21:728-36. 2012..We estimated how much of these disparities could be explained by differences in CRC screening and stage-specific relative CRC survival... - Anxiety and borderline PAP smear resultsIda J Korfage
Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, Room Ae 108, PO Box 2040, 3000 CA Rotterdam, The Netherlands
Eur J Cancer 46:134-41. 2010..We compared quality of life and anxiety in women with BMD and a reference group of screening participants who were awaiting smear taking... - Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysisEsther W de Bekker-Grob
Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
Cancer Causes Control 23:1323-31. 2012..Based on the results of a Dutch randomised controlled trial, we conducted cost-effectiveness threshold analyses to investigate under what circumstances manually screened ThinPrep LBC is cost-effective for screening... - At what costs will screening with CT colonography be competitive? A cost-effectiveness approachIris Lansdorp-Vogelaar
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Int J Cancer 124:1161-8. 2009..Our estimate of 43% is considerably lower than previous estimates in literature, because previous studies only compared CTC screening to 10-yearly colonoscopy, where we compared to different intervals of colonoscopy screening... - How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatmentIris Vogelaar
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Cancer 107:1624-33. 2006..This study assessed the potential reduction in CRC mortality that may be achieved through further dissemination of current interventions for risk-factor modification, screening, and treatment... - Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelinesAagje G Bais
Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Int J Cancer 116:122-9. 2005..For hrHPV positive women, a repeat hrHPV test after another 6 months is suggested. Referral is only required if persistence of hrHPV is established... - No increased risk for cervical cancer after a broader definition of a negative Pap smearMatejka Rebolj
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Int J Cancer 123:2632-5. 2008.... - National Polyp Study data: evidence for regression of adenomasFranka Loeve
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Int J Cancer 111:633-9. 2004..This lowers the expectations for the effects of colorectal cancer screening strategies that focus on adenoma detection... - Health-related quality of life in cervical cancer survivors: a population-based surveyIda J Korfage
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Int J Radiat Oncol Biol Phys 73:1501-9. 2009..In a population-based sample of cervical cancer survivors, health-related quality of life (HRQoL) was assessed 2-10 years postdiagnosis... - Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation modelInge M C M de Kok
Erasmus MC, University Medical Center, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
BMJ 344:e670. 2012.... - A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trialsIris Lansdorp-Vogelaar
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Cancer 115:2410-9. 2009..In addition to 2 usual hypotheses on the sensitivity of FOBT, we tested a novel hypothesis where sensitivity is linked to the stage of clinical diagnosis in the situation without screening... - Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysisJanneke A Wilschut
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
Cancer Causes Control 21:2287-93. 2010..Our aim is to estimate the relative difference in adenoma prevalence and its age-pattern in individuals with a family history of colorectal cancer compared to those without... - Informed choice on Pap smear still limited by lack of knowledge on the meaning of false-positive or false-negative test resultsIda J Korfage
Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Patient Educ Couns 85:214-8. 2011..Screening for cervical cancer may have favourable or unfavourable effects at the individual level. This study assesses whether invitees in The Netherlands made an informed choice about screen uptake... - Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?Inge M C M de Kok
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Int J Cancer 128:2174-81. 2011..On top of that there was an extra decrease that was compensated by a following recent increase in incidence, probably resulting from reorganization of the Dutch screening program... - Cost-effectiveness analysis of human papillomavirus vaccination in the NetherlandsInge M C M de Kok
Department of Public Health, Erasmus MC, University Medical Center, 3000 CA Rotterdam, The Netherlands
J Natl Cancer Inst 101:1083-92. 2009..We examined the effect on cervical cancer incidence and mortality of adding HPV vaccination to the current Dutch cervical cancer screening situation and calculated the cost-effectiveness... - Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the NetherlandsMatejka Rebolj
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Int J Cancer 120:806-12. 2007..In conclusion, the 1996 changes in protocols and guidelines, and their implementation have increased coverage and efficiency, and decreased the screening-induced negative side effects... - Human papillomavirus testing for triage of women referred because of abnormal smears. a decision analysis considering outcomes and costsWillem Jan Meerding
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
J Clin Epidemiol 55:1025-32. 2002..For women with severe dyskaryosis, direct treatment should be seriously considered... - Girls' preferences for HPV vaccination: a discrete choice experimentEsther W de Bekker-Grob
Department of Public Health, Erasmus MC University Medical Centre Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
Vaccine 28:6692-7. 2010.... - Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the NetherlandsAnita B Bos
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Int J Cancer 119:2372-5. 2006..We conclude that increasing screening participation has much more potential for further reducing cervical cancer incidence than reducing the screening interval, increasing the age range or having a screening test with higher sensitivity... - Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohortsJames F O'Mahony
Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands
Value Health 14:438-42. 2011..To call attention to the influence of the number of birth-cohorts used in cost-effectiveness analysis (CEA) models on incremental cost-effectiveness ratios (ICERs) under differential discounting... - Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?Inge M C M de Kok
Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Eur J Cancer 47:428-35. 2011..Observed combinations of these parameters in different countries show a decrease in the CER between 10% and 31%... - [Unequal discounting of health care costs and effects causes confusion]Marjolein van Ballegooijen
Erasmus Medisch Centrum, afd Maatschappelijke Gezondheidszorg, Rotterdam, The Netherlands
Ned Tijdschr Geneeskd 154:A1970. 2010..We show how the use of unequal discount rates leads to confusing cost-effectiveness results and why further implementation guidelines are essential... - Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful informationJames F O'Mahony
Department of Public Health, Erasmus MC, Erasmus University, Rotterdam, The Netherlands
Med Decis Making 33:407-14. 2013.... - Cost-effectiveness of cervical cancer screening: comparison of screening policiesM Elske van den Akker-van Marle
Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands
J Natl Cancer Inst 94:193-204. 2002..e., Pap smears). We compared the efficiency of cervical cancer-screening programs by performing a cost-effectiveness analysis of cervical cancer-screening policies from high-income countries... - Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendanceAafke H C van Roon
Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
Clin Gastroenterol Hepatol 9:333-9. 2011..There are not much data on the optimal number of FITs to perform. We conducted a population-based trial to determine attendance and diagnostic yield of 1- and 2-sample FIT screening... - Women show mixed intentions regarding the uptake of HPV vaccinations in pre-adolescents: a questionnaire studyIda J Korfage
Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Eur J Cancer 44:1186-92. 2008..The general introduction of HPV vaccination, as the primary prevention of cervical cancer, is the subject of debate in the Netherlands...